240 related articles for article (PubMed ID: 24036895)
1. Low platelet iPLA₂ activity predicts conversion from mild cognitive impairment to Alzheimer's disease: a 4-year follow-up study.
Gattaz WF; Talib LL; Schaeffer EL; Diniz BS; Forlenza OV
J Neural Transm (Vienna); 2014 Feb; 121(2):193-200. PubMed ID: 24036895
[TBL] [Abstract][Full Text] [Related]
2. Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
Zainaghi IA; Talib LL; Diniz BS; Gattaz WF; Forlenza OV
J Neural Transm (Vienna); 2012 Jul; 119(7):815-9. PubMed ID: 22573143
[TBL] [Abstract][Full Text] [Related]
3. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
4. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
[TBL] [Abstract][Full Text] [Related]
5. Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.
Teixeira AL; Diniz BS; Campos AC; Miranda AS; Rocha NP; Talib LL; Gattaz WF; Forlenza OV
Neuromolecular Med; 2013 Mar; 15(1):115-21. PubMed ID: 23055000
[TBL] [Abstract][Full Text] [Related]
6. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
8. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
[TBL] [Abstract][Full Text] [Related]
9. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
10. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
11. Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study.
McGuinness B; Fuchs M; Barrett SL; Passmore AP; Johnston JA
J Alzheimers Dis; 2016; 49(4):1095-103. PubMed ID: 26639974
[TBL] [Abstract][Full Text] [Related]
12. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.
García-Herranz S; Díaz-Mardomingo MC; Peraita H
J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
15. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
[TBL] [Abstract][Full Text] [Related]
16. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
17. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
Park JH; Park H; Sohn SW; Kim S; Park KW
Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
[TBL] [Abstract][Full Text] [Related]
18. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
19. Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia.
Tien YT; Lee WJ; Liao YC; Wang WF; Jhang KM; Wang SJ; Fuh JL
Sci Rep; 2019 Dec; 9(1):18691. PubMed ID: 31822765
[TBL] [Abstract][Full Text] [Related]
20. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
